Company / Revenue
Benitec Biopharma Inc. Revenue History
FY2020-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$102.0K
FY2021
5-year range
$102.0K / $12.2M
FY2020-FY2021
Trend
-99.2%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$102,000 in FY2021.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, revenue decreased 99.2% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.32 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | $102.0K | -99.2% |
| FY2020 | $12.2M | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026